LeMaitre Vascular Earnings Estimate

LMAT Stock  USD 99.06  0.83  0.84%   
The next projected EPS of LeMaitre Vascular is estimated to be 0.49 with future projections ranging from a low of 0.4775 to a high of 0.4925. LeMaitre Vascular's most recent 12-month trailing earnings per share (EPS TTM) is at 1.83. Please be aware that the consensus of earnings estimates for LeMaitre Vascular is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
LeMaitre Vascular is projected to generate 0.49 in earnings per share on the 31st of December 2024. LeMaitre Vascular earnings estimates show analyst consensus about projected LeMaitre Vascular EPS (Earning Per Share). It derives the highest and the lowest estimates based on LeMaitre Vascular's historical volatility. Many public companies, such as LeMaitre Vascular, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

LeMaitre Vascular Revenue Breakdown by Earning Segment

By analyzing LeMaitre Vascular's earnings estimates, investors can diagnose different trends across LeMaitre Vascular's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 153.4 M in 2025. Pretax Profit Margin is likely to gain to 0.19 in 2025
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

LeMaitre Vascular Earnings Estimation Breakdown

The calculation of LeMaitre Vascular's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of LeMaitre Vascular is estimated to be 0.49 with the future projection ranging from a low of 0.4775 to a high of 0.4925. Please be aware that this consensus of annual earnings estimates for LeMaitre Vascular is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.49
0.48
Lowest
Expected EPS
0.49
0.49
Highest

LeMaitre Vascular Earnings Projection Consensus

Suppose the current estimates of LeMaitre Vascular's value are higher than the current market price of the LeMaitre Vascular stock. In this case, investors may conclude that LeMaitre Vascular is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and LeMaitre Vascular's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
1085.12%
0.49
0.49
1.83

LeMaitre Vascular Earnings History

Earnings estimate consensus by LeMaitre Vascular analysts from Wall Street is used by the market to judge LeMaitre Vascular's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only LeMaitre Vascular's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

LeMaitre Vascular Quarterly Gross Profit

37.18 Million

Retained Earnings is likely to gain to about 139.4 M in 2025. Retained Earnings Total Equity is likely to gain to about 118.1 M in 2025 Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.3 M in 2025.
Hype
Prediction
LowEstimatedHigh
96.9899.06101.14
Details
Intrinsic
Valuation
LowRealHigh
89.15114.54116.62
Details
10 Analysts
Consensus
LowTargetHigh
89.8998.78109.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as LeMaitre Vascular. Your research has to be compared to or analyzed against LeMaitre Vascular's peers to derive any actionable benefits. When done correctly, LeMaitre Vascular's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in LeMaitre Vascular. Note that many institutional investors and large investment bankers can move markets due to the volume of LeMaitre assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards LeMaitre Vascular. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving LeMaitre Vascular's stock price in the short term.

LeMaitre Vascular Earnings per Share Projection vs Actual

Actual Earning per Share of LeMaitre Vascular refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering LeMaitre Vascular predict the company's earnings will be in the future. The higher the earnings per share of LeMaitre Vascular, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

LeMaitre Vascular Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as LeMaitre Vascular, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of LeMaitre Vascular should always be considered in relation to other companies to make a more educated investment decision.

LeMaitre Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact LeMaitre Vascular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-10-31
2024-09-300.440.490.0511 
2024-08-01
2024-06-300.470.520.0510 
2024-05-02
2024-03-310.390.440.0512 
2024-02-27
2023-12-310.360.380.02
2023-11-01
2023-09-300.30.330.0310 
2023-08-01
2023-06-300.320.360.0412 
2023-05-02
2023-03-310.250.270.02
2023-02-23
2022-12-310.260.25-0.01
2022-10-27
2022-09-300.280.25-0.0310 
2022-07-28
2022-06-300.270.16-0.1140 
2022-04-28
2022-03-310.280.27-0.01
2022-02-24
2021-12-310.310.28-0.03
2021-10-28
2021-09-300.330.3-0.03
2021-07-29
2021-06-300.340.40.0617 
2021-04-29
2021-03-310.270.280.01
2021-02-25
2020-12-310.290.340.0517 
2020-10-29
2020-09-300.190.370.1894 
2020-07-23
2020-06-300.010.210.22000 
2020-04-30
2020-03-310.150.160.01
2020-02-06
2019-12-310.230.230.0
2019-10-23
2019-09-300.210.250.0419 
2019-07-24
2019-06-300.210.230.02
2019-05-01
2019-03-310.190.17-0.0210 
2019-02-19
2018-12-310.20.30.150 
2018-10-04
2018-09-300.210.210.0
2018-07-26
2018-06-300.420.21-0.2150 
2018-04-25
2018-03-310.210.19-0.02
2018-02-21
2017-12-310.20.210.01
2017-10-26
2017-09-300.20.250.0525 
2017-07-27
2017-06-300.170.230.0635 
2017-04-26
2017-03-310.130.160.0323 
2017-02-21
2016-12-310.150.13-0.0213 
2016-10-26
2016-09-300.150.170.0213 
2016-07-27
2016-06-300.110.140.0327 
2016-05-02
2016-03-310.10.110.0110 
2016-02-24
2015-12-310.090.130.0444 
2015-10-27
2015-09-300.080.10.0225 
2015-07-28
2015-06-300.070.10.0342 
2015-04-28
2015-03-310.050.080.0360 
2015-02-25
2014-12-310.070.110.0457 
2014-10-28
2014-09-300.050.050.0
2014-07-29
2014-06-300.050.090.0480 
2014-04-29
2014-03-310.020.01-0.0150 
2014-02-25
2013-12-310.050.050.0
2013-10-29
2013-09-300.040.050.0125 
2013-07-30
2013-06-300.050.060.0120 
2013-05-01
2013-03-310.030.050.0266 
2013-02-26
2012-12-310.050.04-0.0120 
2012-10-30
2012-09-300.040.040.0
2012-07-31
2012-06-300.040.050.0125 
2012-05-02
2012-03-310.040.02-0.0250 
2012-02-27
2011-12-310.060.02-0.0466 
2011-10-27
2011-09-300.070.06-0.0114 
2011-07-28
2011-06-300.080.07-0.0112 
2011-04-28
2011-03-310.050.050.0
2011-02-28
2010-12-310.060.110.0583 
2010-10-28
2010-09-300.080.090.0112 
2010-07-28
2010-06-300.060.090.0350 
2010-04-29
2010-03-310.050.060.0120 
2009-10-28
2009-09-300.010.080.07700 
2009-07-29
2009-06-300.030.060.03100 
2009-04-28
2009-03-31-0.17-0.120.0529 
2008-10-29
2008-09-30-0.03-0.010.0266 
2008-07-29
2008-06-30-0.05-0.06-0.0120 
2008-04-30
2008-03-31-0.08-0.17-0.09112 
2008-03-04
2007-12-31-0.04-0.08-0.04100 
2007-11-05
2007-09-30-0.05-0.09-0.0480 
2007-08-01
2007-06-30-0.040.010.05125 
2007-05-03
2007-03-31-0.03-0.04-0.0133 
2007-02-28
2006-12-31-0.05-0.050.0

About LeMaitre Vascular Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of LeMaitre Vascular earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current LeMaitre Vascular estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as LeMaitre Vascular fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings132.7 M139.4 M
Retained Earnings Total Equity112.4 M118.1 M
Earnings Yield 0.02  0.02 
Price Earnings Ratio 48.17  60.12 
Price Earnings To Growth Ratio 0.84  0.89 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.